Human Rights Constraints on Population-Wide Genetic Screening Programs

1. Introduction

Population-wide genetic screening refers to the systematic testing of individuals or large groups to identify genetic variations associated with inherited diseases, hereditary cancer risks, carrier status, or susceptibility to particular medical conditions. Such programs may help detect diseases early, prevent avoidable suffering, and improve public health planning. However, they also raise significant human rights concerns relating to privacy, informed consent, equality, human dignity, bodily autonomy, and discrimination.

Human rights law does not necessarily prohibit population-wide genetic screening. Instead, it requires that screening programs have a legitimate public health purpose, rely on scientifically valid methods, protect genetic information, and respect individual autonomy. Mandatory screening, unrestricted genetic databases, and the use of genetic results for employment, insurance, or social exclusion may create serious legal difficulties.

The principal objective is to balance public health benefits with the fundamental rights of individuals and communities.

2. Right to Privacy and Genetic Data Protection

Genetic information is particularly sensitive because it may reveal an individual's present health, future disease risks, biological relationships, and information about relatives. Once collected, it may be difficult to make such information completely anonymous.

Population-wide screening programs must therefore establish strict rules governing the collection, storage, processing, sharing, and deletion of genetic data. Access should be limited to authorised persons, and secondary uses should be subject to appropriate legal safeguards.

In India, Article 21 of the Constitution protects life and personal liberty, including the right to privacy. The Digital Personal Data Protection Act, 2023, may also be relevant to digital personal data processed through screening systems, subject to its scope, commencement, and applicable exemptions.

Relevant case law:

Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1: The Supreme Court recognised privacy as a fundamental right under Article 21 and Part III of the Constitution. Genetic screening programs that collect or process personal data must therefore be assessed against constitutional privacy principles, including legality, legitimate purpose, and proportionality.

S. and Marper v. United Kingdom (2008), European Court of Human Rights: The Court found that the indefinite retention of fingerprints and DNA profiles of individuals who had not been convicted violated Article 8 of the European Convention on Human Rights. The judgment illustrates the importance of limiting the retention of genetic information.

These authorities support safeguards against unnecessary collection, indefinite retention, and unauthorised disclosure of genetic information.

3. Informed Consent and Bodily Autonomy

Informed consent requires individuals to understand the purpose of screening, the nature of the test, its potential benefits and limitations, and the possible consequences of receiving results. Participants should ordinarily be free to decline testing without punishment or unreasonable disadvantage.

Consent is especially important where testing reveals unexpected findings, carrier status, or risks of future illness. Individuals should receive understandable information about whether results will be shared with relatives, researchers, public authorities, or commercial entities.

Consent may be complicated when screening is offered to newborns, children, or persons who lack decision-making capacity. In such cases, decisions must be guided by applicable law, the individual's best interests, and the purpose of screening.

Relevant case law:

Samira Kohli v. Dr. Prabha Manchanda (2008) 2 SCC 1: The Supreme Court of India explained the requirements of valid medical consent and emphasised that consent must be real and informed. The principles are relevant to genetic screening, particularly where participants must understand the proposed procedure and its material implications.

Montgomery v. Lanarkshire Health Board [2015] UKSC 11: The UK Supreme Court emphasised the importance of disclosing material risks and reasonable alternatives to enable patients to make informed decisions. This reasoning is relevant when explaining the implications of genetic tests.

Population-wide screening should not become a mechanism through which individuals are tested without meaningful choice merely because testing is administratively convenient.

4. Prohibition of Genetic Discrimination

Genetic screening may lead to discrimination when individuals are treated unfavourably because of inherited conditions, carrier status, or predicted future illness. Employers might reject applicants, insurers might impose restrictions, or communities might stigmatise families carrying particular genetic variations.

Article 14 of the Indian Constitution guarantees equality before the law and equal protection of the laws. Article 21 also protects dignity and personal liberty. Depending on the circumstances, discriminatory screening practices may violate constitutional protections or applicable statutory provisions.

Relevant case law:

National Legal Services Authority v. Union of India (2014) 5 SCC 438: The Supreme Court recognised the importance of dignity, equality, and protection against discrimination. Although the case did not concern genetics, its constitutional principles are relevant when assessing whether genetic classifications produce unequal treatment.

S. and Marper v. United Kingdom (2008): The Court's concerns about retaining sensitive DNA information also demonstrate the risks of using genetic profiles to categorise individuals and potentially expose them to unequal treatment.

UNESCO's Universal Declaration on the Human Genome and Human Rights, particularly Article 6, expressly rejects discrimination based on genetic characteristics that infringes human rights or human dignity.

Legal Affairs

+1

5. Human Dignity, Equality, and Social Stigmatisation

Population-wide genetic screening must not treat genetic differences as evidence that certain individuals are inferior, undesirable, or less entitled to reproduce. Screening programs intended to prevent inherited diseases must be distinguished from coercive eugenic policies that seek to control reproduction or eliminate particular genetic characteristics.

Authorities should also avoid presenting genetic risk as a certain prediction of future illness. Many conditions involve complex interactions between genes, environment, and lifestyle.

In Suchita Srivastava v. Chandigarh Administration (2009) 9 SCC 1, the Supreme Court recognised reproductive autonomy as part of personal liberty under Article 21. This principle is relevant where genetic screening results influence decisions about pregnancy or reproductive choices.

Accordingly, genetic counselling should provide balanced information and support voluntary decisions rather than pressure individuals into sterilisation, pregnancy termination, or other reproductive outcomes.

6. Public Health Necessity and Proportionality

Governments may have legitimate reasons to introduce screening for serious, treatable, or preventable genetic conditions. However, compulsory testing or large-scale data collection should not be justified merely by administrative convenience.

A rights-compliant program should demonstrate:

A clear legal basis and legitimate public health objective.

Scientific validity, clinical utility, and an appropriate assessment of risks and benefits.

The least restrictive reasonably effective approach.

Independent ethical oversight and accessible complaint mechanisms.

Confidentiality, secure data storage, and limits on retention and secondary use.

Equal access to testing, counselling, confirmatory diagnosis, and appropriate treatment.

The Puttaswamy judgment requires restrictions on privacy to satisfy legality, legitimate purpose, and proportionality.

Indian Kanoon

+1

7. Conclusion

Human rights constraints are essential to ensure that population-wide genetic screening serves healthcare objectives without undermining privacy, autonomy, equality, or dignity. Indian constitutional principles, international human rights standards, and relevant judicial decisions support safeguards against coercive testing, genetic discrimination, excessive data retention, and reproductive interference.

The central legal principle is that public health objectives must be pursued through scientifically justified, proportionate, and rights-respecting measures. Genetic screening should empower individuals to make informed healthcare decisions rather than expose them to surveillance, stigma, or unequal treatment.